
Figure 1: Serological immune responses and neutralization titers against SARS-CoV-2 wild variant in time (C) and by different therapies (A-B, D-E).
Figure 1: Serological immune responses and neutralization titers against SARS-CoV-2 wild variant in time (C) and by different therapies (A-B, D-E).